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Objective: Diabetes is a risk factor for dementia and mild cognitive impairment. The aim of
this study was to investigate whether some features of resting-state EEG (rsEEG) could be
applied as a biomarker to distinguish the subjects with amnestic mild cognitive impairment
(aMCI) from normal cognitive function in type 2 diabetes.
Materials and Methods: In this study, 28 patients with type 2 diabetes (16 aMCI patients
and 12 controls) were investigated. Recording of the rsEEG series and neuropsychological
assessments were performed. The rsEEG signal was first decomposed into delta, theta,
alpha, beta, gamma frequency bands. The relative power of each given band/sum of power
and the coherence of waves from different brain areas were calculated. The extracted
features from rsEEG and neuropsychological assessments were analyzed as well.
Results: The main findings of this study were that: (1) compared with the control
group, the ratios of power in theta band [P(theta)] vs. power in alpha band [P(alpha)]
[P(theta)/P(alpha)] in the frontal region and left temporal region were significantly higher
for aMCI, and (2) for aMCI, the alpha coherences in posterior, fronto-right temporal,
fronto-posterior, right temporo-posterior were decreased; the theta coherences in left
central-right central (LC-RC) and left posterior-right posterior (LP-RP) regions were also
decreased; but the delta coherences in left temporal-right temporal (LT-RT) region were
increased.
Conclusion: The proposed indexes from rsEEG recordings could be employed to track
cognitive function of diabetic patients and also to help in the diagnosis of those who
develop aMCI.
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INTRODUCTION
That diabetes affects cognitive function was first reported by Mile
and Root in the 1920s (Miles and Root, 1922). Diabetes patients
were found to have neuronal death and axonal degeneration, a
concept of “diabetic encephalopathy” was thus raised in Gispen
and Biessels (2000). Epidemiological data showed that the dia-
betic patients was associated with a 1.5–2.5-fold increased risk of
dementia (Strachan et al., 2011).
The MCI is defined as impairment in cognitive functions, par-
ticularly memory, with otherwise normal performance of activ-
ities of daily living. The MCI lies between and overlaps normal
aging and Alzheimer’s disease (AD) and is now recognized to be
a risk factor for AD (Levey et al., 2006) or an early manifestation
of the disease (Morris, 2005). The MCI includes two subtypes:
amnestic mild cognitive impairment (aMCI) and non-amnestic
MCI (na-MCI). The aMCI patients are the high-risk groups of
AD. The percent change of conversion from aMCI to AD was
54% and the conversion duration from initial diagnosis of aMCI
to dementia was 28 ± 12 months (Seo et al., 2012).
Type 2 diabetes, is characterized by high blood glucose in
the context of insulin resistance and relative insulin deficiency
(Kumar et al., 2005). Cognitive impairment such as learning
and memory deficiency was seen in type 2 diabetes (Peila et al.,
2002). The diabetes may be associated with increased risk of both
aMCI and na-MCI (Shimada et al., 2010; Roberts et al., 2014).
Therefore, it is critical to explore methods to detect the aMCI of
diabetes patients, so that the early interventions to these patients
can be provided.
Petersen described theMCI based on clinical criteria (Petersen,
2004), however current proposals also include biomarkers (Albert
et al., 2011). By using the ligand-based positron emission tomog-
raphy (PET), abnormal dosages of the beta amyloid to tau ratio
in cerebrospinal fluid (CSF) and deposition of beta amyloid
in the brain can be used to diagnose the prodromal stages of
AD in MCI subjects; moreover, the neurodegeneration such as
atrophy of the hippocampus on magnetic resonance imaging
(MRI) and hypometabolism of the posterior cingulate/precuneus,
parietal and temporal regions revealed by fluorodeoxyglucose
(FDG)-PET are all useful biomarkers for diagnosis of prodro-
mal stages of AD (Albert et al., 2011). However, the sensitivity
and specificity of these biomarkers were different for the different
international databases (Toussaint et al., 2012; Takahashi et al.,
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2013). Moreover, the CSF markers are invasive, the PET markers
are costly and expose patients to radiation, and the MRI mark-
ers of hippocampus volume are relatively expensive for serial
screening of large elderly populations at risk for AD; therefore,
a non-invasive and cost-effective tool is needed. It was demon-
strated that the cerebral EEG rhythms can reflect the underlying
brain network activity (Steriade, 2006), and the resting-state EEG
(rsEEG) can be used to perform serial examinations for neurolog-
ical evolution (Rossini et al., 2007; Schmidt et al., 2013). Recent
studies have investigated the rsEEG rhythms in MCI and AD sub-
jects, which may be a promising approach to assess MCI subjects
(Babiloni et al., 2014). This technique is low-cost, easy to use,
presents a high temporal resolution and is non-invasive.
Spectral power of EEG series and their correlations with neu-
ropsychological tests can provide valuable information in distin-
guishing normal and diseased brain function (Roh et al., 2011).
The theta and delta spectral power tended to increase in the
selected brain regions according to cognitive impairment from
normal through aMCI to AD, whereas alpha and beta2 power
showed a decreasing tendency (Roh et al., 2011). In particular,
relative power has been used as a feature to classify the MCI and
mild AD patients from age-matched controls (Jelic et al., 1996;
Dauwels et al., 2011). In addition, the EEG coherence has been
used to evaluate the functionality of cortical connections and to
provide information about the synchronization of the regional
cortical activity in AD. In Sankari et al. (2011), it was found that
decreased coherence indicates a decline in cortical connectivity
in AD, which suggests that the coherence of EEG signals have
potentials in differentiation of healthy elderly from AD patients.
Power and coherence were considered as features for the clas-
sification of the AD and control groups, since the classification
accuracy reached to 89% (Strijers et al., 1997; Stevens et al., 2001).
Therefore, rsEEG indexes may have the potential as a biomarker
to distinct the aMCI or AD from controls. In order to seek a bet-
ter early diagnosis method of aMCI for patients with diabetes,
rsEEG indexes (relative power and coherence in different regions
and frequencies) were investigated in this study.
MATERIALS AND METHODS
PARTICIPANTS
In this study the participants were 28 right-handed type 2 dia-
betes patients who satisfied the diagnosis criteria for diabetes
(American Diabetes Association, 2013), and they were all volun-
tary and more than 50 years old. These participants were divided
into 2 groups: aMCIs and controls. The aMCI group consisted
of 16 patients (5 males and 11 females; mean age 69.7 ± 8.4
years, range from 52 to 84 years; mean years of diabetes 9.3 ± 2.4
years, range from 1 to 20 years; mean years of education 12.9 ±
1.8 years, range from 6 to 16 years), and the control group con-
sisted of 12 patients (6 males and 6 females; mean age 73.3 ± 4.6
years, range from 63 to 80 years; mean years of diabetes 14.0± 3.1
years, range from 1 to 30 years; mean years of education 13.8 ±
3.0 years, range from 9 to 19 years). Both groups were matched in
age, diabetes duration and education level, but not in gender.
The study was approved by the local ethics committee and
all patients gave written informed consent. The experiment
was conducted in accordance with the Declaration of Helsinki
(1964) and was approved by the Beijing Normal University ethics
committee.
NEUROPSYCHOLOGICAL TESTS AND INCLUSION CRITERIA
Based on traditional MMSE (Folstein et al., 1975), and consid-
ering the China National State, a modified MMSE proposed by
Shanghai Mental Health Center in China (Jia, 2010) was per-
formed to all diabetic participants in this study. The cut-off score
for absence of dementia was 24 points for high school and above,
20 points for the primary, and 17 for the illiteracy participants, so
the scores of the two groups were all more than 24 points, which
included MCI and normal function participants. The MoCA uses
a cut-off score 26 points for MCI (Nasreddine et al., 2005).
Compared with MMSE, the MoCA appears to be a better screen-
ing tool for MCI in the diabetic population because it possesses
higher sensitivity (67%) (Alagiakrishnan et al., 2013). Therefore,
in this study cognitive disorders were further screened by using
MoCA after the preliminary screening of MMSE, which was only
used to rule out AD preliminarily.
In this study, besides MMSE and MoCA, Auditory Verbal
Learning Test (AVLT) (AVLT-Immediate recall, AVLT-Delayed
recall, AVLT-Delayed recognition) (Carlesimo et al., 1996),
Wechsler Adult Intelligence Scale Digit Span Test (WAIS-DST)
(Orsini et al., 1987), Boston Naming Test (BNT), Trail Making
Test (Reitan, 1958), Verbal Fluency Test (Novelli, 1986), Daily
Living Test (Lawton and Brody, 1969) were performed to each
subject.
The participants were all type 2 diabetes patients, whose vision
and hearing were able to complete clinical trials. They under-
went MRI examination to rule out the organic brain disease.
The depression that can cause cognitive impairment was ruled
out using DSM IV criteria for depression (American Psychiatric
Association, 1994). No patients in either group reported a history
of mental illness, systemic disease (such as liver and kidney dys-
function, heart disease and thyroid disease) and nervous system
disease (such as cerebrovascular disease, traumatic brain injury,
epilepsy, encephalitis, hydrocephalus, brain tumors, multiple scle-
rosis, radiation injury) that resulting to cognitive impairment.
The diabetic aMCI patients satisfied the criteria (Petersen,
2004) for the study diagnosis of aMCI. The inclusion criteria
were as follows: (1) memory complaint usually coming from
the patients or their family; (2) objective memory impairment
for age defined by performances ≥1.5 standard deviation below
the mean value of age- and education-matched controls for the
Auditory Verbal Learning Test (Carlesimo et al., 1996); (3) essen-
tially preserved general cognitive function tested using MMSE
and MoCA; (4) normal activities of daily living evidenced by
Activity of Daily Living Scale (Lawton and Brody, 1969); (5) not
demented [the dementia was ruled out by DSM IV criteria for
dementia (American Psychiatric Association, 1994)].
EEG RECORDING
The experiment was performed in the Department of Neurology,
General Hospital of Second Artillery Corps of PLA, Beijing,
China. The participants were asked to wash and brush their hair
before the application of the Geodesic Sensor Net (GSN) to their
head. During recordings, they were asked to close their eyes and
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sit in a comfortable armchair, keeping relaxed and awake for
5min in a quiet-dim room, with room temperature keeping at
23 ± 2◦C.
The EEG data recording was performed with a high-density
128-channel EGI system of Net Amps 300 amplifiers (Electrical
Geodesics Inc. [EGI], Eugene, OR). The EEG was recorded
continuously with a 128-channel GSN using the vertex sen-
sor (Cz) as the reference electrode. Direct current acquisi-
tion was used and the data were sampled at 1000Hz during
recording. The impedances of all electrodes were kept below
50 k, as recommended for this type of amplifiers by EGI
guidelines.
EEG PREPROCESSING
The recorded EEG data were analyzed off-line using NetStation
4.5 software (Electrical Geodesics). First, a band-pass filter of
1–45Hz was applied; then the data were re-referenced to the aver-
age of 57 (left mastoid process) and 100 (right mastoid process)
sensors, and the data were re-sampled to 500Hz. The artifacts
(such as ocular and muscular) were removed by visual inspec-
tion of the raw EEG data. Finally EEG recordings of 3min were
segmented for further analysis.
The data was recorded using the 128-channel GSN, but in this
study, the interested electrodes were circled inside the dashed line
(see Figure 1), which can throughout the whole brain area. In
order to detect EEG power in different regions and inter-/intra-
regions coherence, the brain were divided into five regions: frontal
FIGURE 1 | The electrodes distribution of 128-channel Geodesic
Sensor Net interested electrodes’ partition. The interested electrodes
were those inside the black dotted line. Thick solid lines divided the
interested electrodes into 5 regions: the number 1, 2, 3, 4, and 5 denote
the frontal, left temporal, central, right temporal and posterior regions,
respectively. Vertical dotted line divided the brain into left and right
hemispheres (LH and RH), left frontal (LF) and right frontal (RF), left central
(LC) and right central (RC), and left posterior (LP) and right posterior (RP).
(F), left temporal (LT), central (C), right temporal (RT), and
posterior (P). For the aim to estimate the left and right hemi-
spheres paired-electrodes coherence, the vertical dashed line (see
Figure 1) divided the brain into left and right hemispheres (LH
and RH) and the frontal region was divided into left frontal (LF)
and right frontal (RF), the central region into left central (LC) and
right central (RC), the posterior into left posterior (LP) and right
posterior (RP).
EEG DATA ANALYSIS
In this study, power and coherence were calculated at the five fre-
quency bands: delta (1–4Hz), theta (4–8Hz), alpha (8–13Hz),
beta (13–30Hz), gamma (30–45Hz). For each band, the relative
power and the coherence were obtained. The EEG data of 10 s
were divided into overlapping segments using periodic 2-s ham-
ming windows with 50% overlap, then the power spectral density
(PSD) and the coherence of were computed using pwelch method
(Welch, 1967). Outliers rejection was performed by means of a
generalized extreme studentized deviate (GESD) (Seem, 2007) for
all epochs.
Relative power
The relative power of each given band/sum of power from 1 to










where P(·) indicates the power, RP(·) indicates the relative power,
and f1, f2 indicate the low and high frequency, respectively.
The ratios of power for different frequency bands in each elec-
trode was computed for possible pairs of frequency bands, such
as P(delta)/P(theta) [or /P(alpha), or /P(beta), or /P(gamma)],
P(theta)/P(alpha) [or /P(beta), or /P(gamma)], P(alpha)/P(beta)
[or /P(gamma)] and P(beta)/P(gamma).
The relative power for each band and the ratios of power for
different frequency bands were averaged in each region.
Coherence
In this study, the magnitude squared coherence Cxy of signals x
and y was estimated by using the PSD (Pxx and Pyy) and the cross




where f is the frequency. In this study, Welch’s averaged (a mod-
ified period-gram method) (Welch, 1967) was used to compute
the coherence. Compared with other power spectra estimating
methods, it is better to against noise. In the calculation, the fre-
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where U and L were the upper and the lower bound frequencies
for each band. The coherence of each pair of electrodes over the
five frequency bands for each subject was calculated. After outlier
rejection, the remained epochs were averaged. From this point,
we called the averaged coherence as coherence.
Table 1 | Neuropsychological assessment scores (mean ± s.e.m.) and
p values for the tested items in the diabetic aMCI and control groups.
Items aMCI (n = 16) Control (n = 12) P values
MMSE 27.9 ± 0.5 28.8 ± 0.2 0.529
MoCA 22.4 ± 0.5 27.0 ± 0.3 p < 0.0001***
AVLT-Immediate recall 5.4 ± 0.4 7.6 ± 0.5 0.002*
AVLT- Delayed recall 4.3 ± 0.9 8.8 ± 1.0 0.005**
AVLT- Delayed recognition 10.9 ± 0.9 13.8 ± 0.3 0.008**
BNT 18.7 ± 0.4 19.8 ± 0.1 0.048*
WAIS-DST 11.5 ± 0.7 14.6 ± 0.6 0.002**
Trail Making Test1 65.4 ± 5.3 58.8 ± 4.9 0.354
Trail Making Test2 112.3 ± 14.3 99.9 ± 10.0 0.699
Verbal Fluency Test 15.6 ± 0.8 18.0 ± 0.1 0.099
Activity of Daily Living Scale 14 14 —
Key: MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive
Assessment; AVLT, Auditory Verbal Learning Test; BNT, Boston Naming Test;
WAIS-DST, Wechsler Adult Intelligence Scale Digit Span Test; aMCI, amnestic
mild cognitive impairment; MCI, mild cognitive impairment; s.e.m., Standard
Error of the Mean. *p < 0.05; **p < 0.01; ***p < 0.001.
The intra-/inter-coherence in the five different regions and the
paired-electrodes coherence (e.g., 22-9, 26-2, 45-108 and so on)
over the left and right hemispheres were calculated.
STATISTICAL ANALYSIS
In this study, Wilcoxon rank sum test was conducted at the 5%
significance level including the EEG relative power of each brain
area, the inter hemispheric coherence along with the intra-/inter-
coherence in the five regions and the neuropsychological scores
between aMCI and controls.
In order to determine whether rsEEG can be biomarkers to
detect aMCI in diabetes, the correlations between the significantly
different neuropsychological items and the EEG indexes over sig-
nificantly different regions in significantly different bands were
analyzed in the diabetic aMCI and control groups. Pearson’s linear
correlation was employed in this study.
RESULTS
NEUROPSYCHOLOGICAL TESTS
The neuropsychological assessment scores of the aMCIs and con-
trols (the p values for the tested items) were shown in Table 1.
There were significant differences in scores of MoCA, AVLT-
Immediate recall, AVLT-Delayed recall, AVLT-Delayed recogni-
tion, BNT, WAIS-DST. The scores of MMSE, Trail Making Test,
Verbal Fluency Test, and Daily Living Skills Test were lower in
aMCI patients than in controls, but these differences were not
statistically significant.
FIGURE 2 | The ratios of P(theta)/P(alpha) in frontal and left temporal
regions and the correlations between the ratios of P(theta)/P(alpha) and
scores of MMSE and MoCA. (A) The ratios of P(theta)/P(alpha) in frontal
region (left panel) and in left temporal region (right panel). (B) The correlation
between ratios of P(theta)/P(alpha) and scores of MMSE in frontal region (left
panel) and in left temporal region (right panel). ∗p < 0.05.
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RELATIVE POWER
The relative power for all frequency bands were not significantly
different in diabetes between the aMCI and control groups, but
the ratios of P(theta)/P(alpha) in the frontal and temporal regions
showed statistically significant differences. Compared to the con-
trol group, the ratios of P(theta)/P(alpha) in the frontal region
(aMCI: 0.78 ± 0.16, control: 0.31 ± 0.07; p < 0.05) and the
left temporal region (aMCI: 0.61 ± 0.09, control: 0.28 ± 0.05;
p < 0.05) were significantly higher in the subjects with aMCI (see
Figure 2A). For the ratios obtained in other regions and at other
frequency bands there are no differences between both groups, the
significant ratios of relative power obtained were then correlated
with those neuropsychological measures in which there were dif-
ferences between controls and aMCI subjects. Figure 2B showed
that the ratios of P(theta)/P(alpha) were negatively correlated
to the scores of MoCA in the frontal (r = −0.485, p = 0.014)
and left temporal (r = −0.518, p = 0.007) regions. There were
no significant correlations between ratios of relative power and
neuropsychological tests.
COHERENCE
In posterior region (intra-region), alpha coherence was lower
for subjects with aMCI (0.54 ± 0.02; p < 0.05) compared to
the controls (0.62 ± 0.02) (see Figure 3A). There were no sig-
nificant differences for coherence at other frequency bands or
regions. Then the correlations between significant different intra-
region coherence and neuropsychological tests were analyzed. No
significant correlation between the alpha coherence and neu-
ropsychological tests was found, including the scores of MoCA
(r = 0.335, p = 0.09) (see Figure 3B).
In inter-regions, alpha coherences in fronto-posterior (control:
0.30 ± 0.02, aMCI: 0.24 ± 0.01; p < 0.01), right temporo-
posterior (aMCI: 0.29 ± 0.01, control: 0.36 ± 0.01; p < 0.01)
were significantly lower for subjects with aMCI than that with
normal cognitive function (Figure 4A). No significant differences
in inter-regions coherence were found between both groups. The
significant different inter-region coherence obtained was then
correlated with those neuropsychological measures in which there
were differences between controls and aMCI subjects. The alpha
coherences in fronto-posterior (r = 0.496, p = 0.009) and right
temporal-posterior (r = 0.691, p = 0.0002) regions were posi-
tively correlated to the scores ofMoCA (see Figure 4B). There was
no significant correlation between alpha coherences and other
neuropsychological tests (data not shown).
In inter-hemispheric coherence, aMCI patients showed higher
coherence values in delta between LT and RT regions (aMCI:
0.24 ± 0.01, control: 0.20 ± 0.01; p < 0.05), and a lower coher-
ence in the theta band in left central-right central (LC-RC) areas
(aMCI: 0.66 ± 0.02, control: 0.72 ± 0.02; p < 0.05)and in left
posterior-right posterior (LP-RP) regions (aMCI: 0.43 ± 0.02,
control: 0.54± 0.03; p < 0.05), than the controls (see Figure 5A).
There were no significant differences in other inter-hemispheric
regions and frequency bands in both groups. The correlation’s
results between the significant inter-hemispheric coherence and
neuropsychological tests which were different in aMCI and con-
trols showed that the delta coherences of left temporal-right
temporal (LT-RT) region were negatively correlated to the MoCA
FIGURE 3 | The alpha coherence in posterior region and the
correlations between the alpha coherence and the scores of MoCA.
(A) Alpha coherence in posterior region. (B) The correlations between the
alpha coherences and the scores of MoCA. ∗p < 0.05.
scores (r = −0.474, p = 0.019), and the theta coherences of LC-
RC region (r = 0.441, p = 0.024) and LP-RP region (r = 0.434,
p = 0.028) were positively correlated to the MoCA scores (see
Figure 5B).
DISCUSSION
Type 2 diabetes or impairment of glucose metabolism may
increase the risk of cognitive impairment and accelerate the
progress from MCI to dementia, and it is up to 80% of patients
with AD (Ganguli et al., 2004; Busse et al., 2006; Yaffe et al., 2006;
Hussain, 2007; Xu et al., 2010; Tuma, 2012; Roberts et al., 2014).
The present study examined whether the ratios of power and
the values of coherence of rsEEG data can be used to distin-
guish aMCI from controls with diabetes. Our findings showed
that the ratios of power in theta band vs. power in alpha band
[P(theta)/P(alpha)] in the frontal region and left temporal region
were significantly higher in aMCI subjects. Besides this, the aMCI
group showed lower values of coherence in the alpha band in
posterior, fronto-right temporal/fronto-posterior/right temporo-
posterior regions and in the theta band in LC-RC and LP-RP
regions than the control group. Finally, the aMCI patients exhib-
ited an increase in coherence in delta band in LT-RT regions,
compared to the control subjects.
In previous studies, rsEEG absolute power were directly used
to evaluate cognitive status of MCI subjects (Luckhaus et al.,
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FIGURE 4 | The alpha coherences in fronto-posterior and right
temporal-posterior regions and the correlations between the
alpha coherences and the scores of MoCA. (A) The alpha
coherences in fronto-posterior (left panel) and right
temporal-posterior (right panel) regions. (B) The correlation
between alpha coherences and scores of MoCA in
fronto-posterior (left panel) and right temporal-posterior (right
panel) regions. ∗∗p < 0.01.
FIGURE 5 | The delta coherences in LT-RT region and theta coherences in
LC-RC and LP-RP regions, and the correlations for the delta coherences
or (and) theta coherences with the scores of MoCA. (A) The delta
coherences in LT-RT region (left panel) and the theta coherences in LC-RC
(middle panel) and LP-RP (right panel) regions. (B) The correlation between
the delta coherences and the scores of MoCA in LT-RT region (left panel), and
the correlations between the theta coherences and the scores of MoCA in
LC-RC (middle panel) and LP-RP (right panel) regions. ∗p < 0.05.
Frontiers in Aging Neuroscience www.frontiersin.org February 2014 | Volume 6 | Article 11 | 6
Bian et al. EEG bio-maker are related to aMCI in diabetes
2008), and specially could reflect neurodegenerative processes in
aMCI (Huang et al., 2000; Jelic et al., 2000; Koenig et al., 2005;
Babiloni et al., 2006). There were decreased alpha (8–10.5Hz)
power in the parieto-occipital regions (Jelic et al., 1996; Babiloni
et al., 2000, 2006; Jelic et al., 2000), significantly increased theta
power in the frontal and temporo-parietal regions (Johnson,
2006) and increased delta power widespread over the brain for
MCI patients (Babiloni et al., 2006). And the significant corre-
lations between power and neuropsychological assessment scores
indicated that aMCI was associated with disruptions in the opera-
tion of neuro-cognitive networks (Cummins et al., 2008). Brismar
(2007) suggested that the theta rhythm increased in frontal and
left central regions, and alpha, beta, and gamma power decreased
in temporal region. And it was found that the alpha and beta
power was lower in MCI (Rodriguez et al., 2011). The increased
slow rhythm power and the reduced fast rhythm power in type
2 diabetic may be associated with cortical damage. However, in
this study the absolute power of rsEEG at the different frequency
bands was not significantly different between the diabetic aMCI
and controls (not shown in the Results section). The possible rea-
son is the rsEEG absolute power was sensitive to non-diabetic’s
brain performances. The relative power and coherence of rsEEG
could be better to indicate aMCI in diabetes.
The relative power of theta and alpha bands was reported as
an important predictor for MCI, which correctly classified MCI
subjects of 85% (Jelic et al., 2000). However, in this study the rela-
tive power for each frequency band was not significantly different
between the diabetic aMCI and control groups. Because of the
complex structure and richest connections with the hippocampus
(Johnson, 2006; Moretti et al., 2007b), the frontal and temporal
regions were more sensitive than other regions. Moreover, it has
been reported that significant increase in the theta/alpha1 ratio
was indicative of cerebrovascular damage (CVD) (Moretti et al.,
2007a,b). Our subjects were all diabetic and may be affected by
CVD. This may be the reason to support the difference between
this study and previous studies. The effects of diabetes on degen-
erative and CVD may accelerate onset of MCI (Roberts et al.,
2014), as insulin-related effects may affect cognitive function
(Craft, 2007). Insulin resistance and hyperinsulinemia increased
brain intra-neuronal β-amyloid deposition and hyperphosphory-
lation of tau (Craft, 2005). And the dysregulation of brain insulin
signaling may lead to impaired central glucose homeostasis and
neurodegeneration. Vascular damage of the brain resulted from
diabetes (Craft, 2005; Debette et al., 2011) may contribute to the
risk of aMCI (Arvanitakis et al., 2006; Knopman and Roberts,
2010; Roberts et al., 2011). It has been demonstrated that vascular
lesions interrupt the cortical cholinergic pathways whichmay lead
to depletion of acetylcholine, resulting in cognitive impairment
(Mitrushina et al., 1999). Therefore, this study suggested that the
ratios of power at some brain areas can be used as a sensitive
index to distinguish aMCI from subjects with normal cognitive
function.
Coherence can reflect functional interactions between neu-
ral networks (Hogan et al., 2003). In Gomez et al. (2009), it
was reported that coherence was lower in all frequency bands in
MCI group, and has been used to detect the brain dysfunction
thus discriminating MCI patients from controls. In this study, we
found that: the alpha coherence decreased in posterior region,
fronto-posterior and right temporo-posterior regions; the theta
coherence decreased in left and right central and left and right
posterior region; and the delta coherence increased in left and
right temporal regions in aMCI subjects compared with con-
trols. There are some differences between these findings and the
reports in Moretti et al. (2008). The decreased alpha coherence
in fronto-posterior and temporo-posterior regions and increased
delta in left and right temporal regions have been also reported
in previous MCI’s studies (Jelic et al., 1996; Jeong, 2004; Babiloni
et al., 2008; Moretti et al., 2008). The coherence changes in the
alpha and delta bands were associated with aMCI and CVD
(Moretti et al., 2008), and authors suggested that the increase of
inter-hemispheric coherence in the temporal region was linked
to hippocampal atrophy, whereas the decrease of coherence in
fronto-parietal regions was linked to subcortical CVD (Moretti
et al., 2008). But for other frequency bands, there was regional
difference or has no difference between our and their studies
(Jeong, 2004; Moretti et al., 2008). In conclusion, this study sug-
gested that the decreased theta, alpha coherence and increased
delta coherence in corresponding regions may distinguish aMCI
from controls in diabetic.
The results of correlations between scores of MoCA and rsEEG
biomarkers indicated that MoCA scores and rsEEG biomark-
ers among frontal, temporal, and posterior regions are well-
correlated. The correlations between other significantly different
neuropsychological items and rsEEG biomarkers were not signif-
icant. It is worth mentioning that the correlation between the
scores of MoCA and alpha coherence was not significant neither.
These results suggested that intra-posterior functional connec-
tions in alpha band may be relatively preserved in diabetic aMCI.
These correlations confirmed the feasibility and value of our
studies aimed at detecting aMCI in diabetes by rsEEG biomark-
ers. And our results evidenced that the sensitivity of MoCA
and its utility in diabetic population were better than MMSE
(Alagiakrishnan et al., 2013) since this test was usually correlated
with the EEG power/coherence.
This study shows the rsEEG may provide efficient methods
to monitor the cortical dysfunction associated with the cogni-
tive decline of diabetic patients. The rsEEG measures may be
eventually assumed a role in early detecting aMCI or in guiding
diagnosis of aMCI in diabetes. Thus, early intervention can be
carried out to slow the development pace of aMCI to AD.
However, these results may still be limited, larger prospective
studies are necessary to verify the findings in this study.
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